Burrill Institutional Research Analyst Recommendations & Stock PicksView the latest stock recommendations issued by analysts at Burrill Institutional Research. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Burrill Institutional Research's equity research team. MarketBeat is not affiliated with or endorsed by Burrill Institutional Research.Updated 7/24/2013 Brokerage RankingSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROITotal Ratings0 Last 12 MonthsBuy Ratings0 Last 12 MonthsSell Ratings0 Last 12 Months Country All Countries USA (NYSE & NASDAQ)USA (All Exchanges)CanadaUnited Kingdom Sector All Sectors AerospaceAuto/Tires/TrucksBasic MaterialsBusiness ServicesCommunication ServicesComputer and TechnologyConstructionConsumer CyclicalConsumer DefensiveConsumer DiscretionaryConsumer GoodsConsumer StaplesEnergyFinanceFinancial ServicesIndustrialsManufacturingMedicalMiscellaneousMulti-Sector ConglomeratesReal EstateRetail/WholesaleServicesTransportationUtilities Market Cap All MarketCaps Mega Cap (More Than $200B)Large Cap ($10B-$200B)Mid Cap ($2B-$10B)Small Cap ($300M-$2B)Micro Cap ($50M-$300M)Nano Cap (Under $50M) MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Reporting Date Full History Latest Per Company Show All Ratings Strong Buy Buy Hold Sell Rating All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Price Target Change Action Any Change Raised 5%+ Raised 10%+ Raised 20%+ Lowered 5%+ Lowered 10%+ Lowered 20%+ Price Target Change Export CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetailsSRPTSarepta Therapeutics$15.68-1.3%7/24/2013 Downgrade$39.00Outperform ➝ Market Perform00.00%View details for Burrill Institutional Research rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/24/2013SRPTSarepta Therapeutics$15.68-1.3%5/13/2013 Reiterated Rating$39.00Outperform00.00%View details for Burrill Institutional Research rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/13/2013NVAXNovavax$7.46-4.6%3/19/2013 Initiated CoverageOutperform00.00%View details for Burrill Institutional Research rating of Novavax (NASDAQ:NVAX) on 3/19/2013SRPTSarepta Therapeutics$15.68-1.3%3/8/2013 Lower Price Target$54.00 ➝ $39.00Outperform00.00%View details for Burrill Institutional Research rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/8/2013SGMOSangamo Therapeutics$0.072/19/2013 Initiated Coverage$28.00Outperform00.00%View details for Burrill Institutional Research rating of Sangamo Therapeutics (NASDAQ:SGMO) on 2/19/2013OMEROmeros$9.79-4.8%12/28/2012 Lower Price Target$19.00 ➝ $16.00Outperform00.00%View details for Burrill Institutional Research rating of Omeros (NASDAQ:OMER) on 12/28/2012SRPTSarepta Therapeutics$15.68-1.3%11/26/2012 Initiated Coverage$54.00Outperform00.00%View details for Burrill Institutional Research rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2012OMEROmeros$9.79-4.8%10/15/2012 Initiated Coverage$17.00Outperform00.00%View details for Burrill Institutional Research rating of Omeros (NASDAQ:OMER) on 10/15/2012 MarketBeat Community Rating for Burrill Institutional ResearchMarketBeat's community ratings are surveys of what our community members think about Burrill Institutional Research and other research firms in the last 90 days. Vote "Outperform" if you believe Burrill Institutional Research's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Burrill Institutional Research's recommendations will underperform the broader market over the long term. You may vote once every thirty days. Log in to vote on this brokerage. COMMUNITY RATINGS0.0out of 5 (last 90 days)0 of 5 stars OUTPERFORM VOTES 0 Believe will outperform the market UNDERPERFORM VOTES 0 Believe will underperform the market Best & Worst CallsBest Call0000.0%NASDAQ:PRANInitiated Coverage • Dec 20, 2012Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NASDAQ:TTNPBoost Price Target • Mar 22, 2013Subscribe to MarketBeat All Access to get analyst recommendation ROI.Similarly Rated FirmsWUWunderlichClarkson CapitalMelius ResearchVentum FinancialNew Street ResearchChina RenaissanceTudor PickeringWeiss RatingsFearnley FondsThinkEquity Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsDeutsche Bank AktiengesellschaftStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
